Medtronic (MDT) Financial Analysis & Valuation | Quarter Chart
Medtronic (MDT)
MDTPrice: $80.93
Fair Value: 🔒
🔒score
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices... more
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems... more
Description
Shares
| Market Cap | $103.59B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | IE | CEO | Geoffrey Straub Martha |
| IPO Date | 1973-05-02 | CAGR | 0.12% |
| Employees | 95,000 | Website | www.medtronic.com |
| Div. Yield | 3.38% | Payout Ratio | 0.76% |
| Buy Back Yield | 0.81% | Total Yield | 4.19% |
MDT chart loading...
Fundamentals
Technicals
| Enterprise Value | $110.29B | P/E Ratio | 14.63 |
| Forward P/E | 12.64 | PEG Ratio | 1.19 |
| P/S Ratio | 2.97 | P/B Ratio | 2.2 |
| P/CF Ratio | 14.77 | P/FCF Ratio | 19.94 |
| EPS | $5.53 | EPS Growth 1Y | 3.04% |
| EPS Growth 3Y | 32.27% | EPS Growth 5Y | 40.23% |
| Revenue Growth 1Y | 8.43% | Gross Margin | 0.45% |
| Operating Margin | 0.19% | Profit Margin | 0.13% |
| ROE | 0.1% | ROA | 0.05% |
| ROCE | 0.08% | Current Ratio | 2.54 |
| Quick Ratio | 2.62 | Cash Ratio | 0.12 |
| Debt/Equity | 0.57 | Interest Coverage | 9.49 |
| Altman Z Score | 2.8 | Piotroski Score | 5 |